Aviva’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Buy |
55,565
+2,858
| +5% | +$625K | 0.03% | 481 |
|
|
2025
Q1 | $11.8M | Buy |
52,707
+7,091
| +16% | +$1.59M | 0.03% | 428 |
|
|
2024
Q4 | $14.9M | Sell |
45,616
-55,024
| -55% | -$18M | 0.04% | 366 |
|
|
2024
Q3 | $30.2M | Buy |
100,640
+2,589
| +3% | +$777K | 0.08% | 288 |
|
|
2024
Q2 | $32.3M | Buy |
98,051
+38,012
| +63% | +$12.5M | 0.09% | 261 |
|
|
2024
Q1 | $23.8M | Buy |
60,039
+13,265
| +28% | +$5.25M | 0.08% | 297 |
|
|
2023
Q4 | $16.5M | Buy |
46,774
+6,633
| +17% | +$2.34M | 0.06% | 368 |
|
|
2023
Q3 | $15.1M | Buy |
40,141
+6,995
| +21% | +$2.62M | 0.06% | 360 |
|
|
2023
Q2 | $12.7M | Sell |
33,146
-119,200
| -78% | -$45.6M | 0.05% | 392 |
|
|
2023
Q1 | $52.8M | Buy |
152,346
+11,665
| +8% | +$4.04M | 0.24% | 81 |
|
|
2022
Q4 | $33.1M | Buy |
140,681
+25,094
| +22% | +$5.91M | 0.16% | 151 |
|
|
2022
Q3 | $28.4M | Buy |
115,587
+14,923
| +15% | +$3.67M | 0.16% | 141 |
|
|
2022
Q2 | $30.4M | Buy |
100,664
+52,653
| +110% | +$15.9M | 0.16% | 136 |
|
|
2022
Q1 | $19.7M | Buy |
48,011
+16,337
| +52% | +$6.71M | 0.1% | 244 |
|
|
2021
Q4 | $14.9M | Sell |
31,674
-2,689
| -8% | -$1.26M | 0.06% | 299 |
|
|
2021
Q3 | $14.6M | Buy |
34,363
+8,706
| +34% | +$3.7M | 0.07% | 291 |
|
|
2021
Q2 | $9.21M | Sell |
25,657
-3,434
| -12% | -$1.23M | 0.04% | 414 |
|
|
2021
Q1 | $8.2M | Sell |
29,091
-717
| -2% | -$202K | 0.04% | 390 |
|
|
2020
Q4 | $8.45M | Sell |
29,808
-2,079
| -7% | -$589K | 0.04% | 364 |
|
|
2020
Q3 | $8.77M | Buy |
31,887
+21,511
| +207% | +$5.91M | 0.05% | 307 |
|
|
2020
Q2 | $2.36M | Sell |
10,376
-14,499
| -58% | -$3.29M | 0.01% | 608 |
|
|
2020
Q1 | $3.79M | Buy |
24,875
+12,230
| +97% | +$1.86M | 0.03% | 497 |
|
|
2019
Q4 | $1.9M | Buy |
+12,645
| New | +$1.9M | 0.01% | 773 |
|
|
2018
Q3 | – | Sell |
-44,143
| Closed | -$4.38M | – | 756 |
|
|
2018
Q2 | $4.38M | Buy |
+44,143
| New | +$4.38M | 0.03% | 562 |
|